Daily news and updates provided by the NEUROSURGERY® Editorial Office

Posts Tagged ‘Keywords: Bevacizumab

Ahead of Print: Neurosurgical Management and Prognosis of Patients with Glioblastoma that Progress During Bevacizumab Treatment

Full article access for Neurosurgery subscribers at

BACKGROUND: The management and prognosis of glioblastoma patients after Stupp protocol treatment and progression during bevacizumab (BV) treatment remains undefined.

OBJECTIVE: We compared the morbidity and survival of patients whose glioblastomas progressed during bevacizumab treatment requiring craniotomy to non-bevacizumab-treated patients.

METHODS: We retrospectively reviewed patients who underwent craniotomy for recurrent glioblastoma from 2005-2009. Patients operated on for progression during bevacizumab (preoperative bevacizumab) were compared to patients receiving no bevacizumab or bevacizumab after surgery (postoperative bevacizumab). Preoperative bevacizumab patients were compared to those progressing on bevacizumab but not operated on (no surgery).

Read the rest of this entry »

Written by NEUROSURGERY® Editorial Office

November 1, 2011 at 2:56 PM


Get every new post delivered to your Inbox.

Join 13,691 other followers